CA3075877A1 — Method for producing retinal tissues
Assigned to Sumitomo Pharma Co Ltd · Expires 2019-03-21 · 7y expired
What this patent protects
The present invention addresses the problem of providing a method for suppressing differentiation of ganglion cells, amacrine cells, horizontal cells, and/or bipolar cells in neural retinal tissues including photoreceptor precursor cells and/or photoreceptor cells, etc. This meth…
USPTO Abstract
The present invention addresses the problem of providing a method for suppressing differentiation of ganglion cells, amacrine cells, horizontal cells, and/or bipolar cells in neural retinal tissues including photoreceptor precursor cells and/or photoreceptor cells, etc. This method for suppressing differentiation of ganglion cells, amacrine cells, horizontal cells, and/or bipolar cells in neural retinal tissues including photoreceptor precursor cells and/or photoreceptor cells comprises a step for culturing, in a medium containing a thyroid hormone signal transduction pathway active substance, retinal tissues that contains neural retinal precursor cells and are in any one of differentiation stages from a differentiation stage just after the emergence of ganglion cells to a stage at which the occurrence rate of pyramidal photoreceptor precursor cells reaches the maximum.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.